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In a 1997 report of a large abdominal aortic aneurysm (AAA) screening study, we observed a negative
association between diabetes and AAA. Although this was not previously described and negative asso-
ciations between diseases are rare, the credibility of the ﬁnding was supported by consistent results in
several previous studies and by the absence of an obvious artifactual explanation. Since that time,
a variety of studies of AAA diagnosis, both by screening and prospective clinical follow-up, have
conﬁrmed the ﬁnding. Other studies have reported slower aneurysm enlargement and fewer repairs for
rupture in diabetics. The seeming protective effect of diabetes for AAA contrasts with its causal role in
occlusive vascular disease and so provides a strong challenge to the traditional view of AAA as a mani-
festation of atherosclerosis. Research focused on a protective effect of diabetes has already increased our
understanding of the etiology of AAA, and might eventually pave the way for new therapies to slow AAA
progression.
Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.In 1995, while preparing the ﬁrst manuscript on the Aneurysm
Detection and Management (ADAM) study ultrasound screening
program results, we encountered the remarkable ﬁnding that dia-
betes appeared to reduce the prevalence of abdominal aortic aneu-
rysm (AAA) by almost half. The cohort, 73,451 veterans aged 50–79
years, was an order of magnitude larger than previous similar
cohorts, raising the possibility of a new ﬁnding, and the effect
was seen both with very small aneurysms and with AAA of 4 cm
in diameter or larger (Table 1).1 However, AAA was traditionally
considered “atherosclerotic” (though arguments had been made
to the contrary2) and the usual risk factors for atherosclerosis,
including diabetes, were assumed to apply. Furthermore, negative
associations or ‘protective effects’ between diseases appear to be
quite rare, though a few have been reported.3,4
Therefore, our ﬁrst reaction was to look for an artifactual expla-
nation for the ﬁnding, i.e. some other reason that the number of
patients with both AAA and diabetes might have been reduced in
our cohort. Two possibilities came to mind, the ﬁrst being that of
competing risk: if AAA were particularly lethal in diabetics, more
patients with both conditions might die before they could be iden-
tiﬁed at AAA screening. However, we knew of no reason why this
combination should be particularly lethal, nor could we ﬁnd any
support for this theory in the literature.1 Second, we had excluded
patients with a previous diagnosis of AAA from our screening
cohort, so if diabetics weremore likely to have AAA diagnosed prior
to screening, perhaps due to more contact with health caretions on this paper, please go
Ltd on behalf of European Societyproviders, then fewer AAA would be left for detection at screening.
If so, the prevalence of diabetes should be increased in patients
with previously diagnosed AAA. We reviewed our records on 849
such patients and found the same low rate of diabetes as in those
with screening-detected AAA,1 strongly suggesting that this was
not the explanation.
We next reviewed the literature looking for data conﬁrming or
refuting our ﬁnding. Though previous AAA screening studies lacked
power to reliably detect the effect, the three largest all reported
non-signiﬁcant trends toward the negative association,5–7 as
shown in Table 1. We also found a cohort study8 in which patients
with the highest quartile of blood sugars had a relative risk of
subsequent diagnosis of AAA of 0.73 compared with the lowest
quartile, though statistical signiﬁcance was not addressed. Most
notably, patients inMassachusetts who had AAA repair had a signif-
icantly lower prevalence of diabetes than controls who had appen-
dectomy.9 The authors of these studies did not comment on the
negative association except in this last paper, where it was noted
only that “if anything, diabetic subjects appear to have lower risk
for aneurysmectomy relative to appendectomy”. Nevertheless, the
Massachusetts study was sufﬁciently different from our own that
a common artifactual explanation seemed unlikely, and we decided
to emphasize the ﬁnding as probably representing a true negative
association.1
Since then, a variety of studies have conﬁrmed the negative
association of diabetes with AAA. Large studies of ultrasound
screening and of prospective clinical diagnosis of AAA (those iden-
tiﬁed through record review in studies that did not employ
screening) are shown in Table 1.1,5–7,10–19 Furthermore, when thefor Vascular Surgery.
Table 1
Odds ratios for diagnosis of AAA in diabetics vs. non-diabetics.
Cohort Age (years) Gender No. subjects No. AAA Odds ratio 95% CI
Ultrasound screening diagnosis of AAA
Smith 19935 65–75 men 2669 219 0.83a NA (NS)
Pleumeekers 19956 >55 both 5419 113 0.83a NA (NS)
Kanagasabay 19967 65–80 both 5392 218 0.80 0.41–1.58 (NS)
Lederle 19971 50–79 97% men 73,451 3.0–3.9 cm: 2217 0.68 0.60–0.77
4.0 cm: 985 0.54 0.44–0.65
Lederle 200010 50–79 97% men 52,745 3.0–3.9 cm: 1237 0.60 0.50–0.71
4.0 cm: 583 0.50 0.39–0.65
Le 200711 65–83 men 12,203 933 0.79 0.63–0.98
Kent 201012 <85 both 3,055,455 23,446 0.75 0.73–0.77
Svensjö 201113 65 men 14,611 233 0.88a NA (NS)
Prospective clinical diagnosis of AAA
Törnwall 200114 50 men 29,133 181 0.43a 0.16–1.15 (NS)
Rodin 200315 >40 both 19,274 418 0.81b NA (NS)
Wong 200716 >40 men 39,352 376 0.55b 0.26–1.17 (NS)
Iribarren 200717 >18 both 104,813 605 0.62b 0.36–1.05 (NS)
Baumgartner 200818 >45 both 68,236 1722 0.59 0.54–0.66
Lederle 200819 >50 women 161,808 184 0.29 0.13–0.68
AAA ¼ abdominal aortic aneurysm, CI ¼ conﬁdence interval, NA ¼ not available, NS ¼ not statistically signiﬁcant at 0.05 level.
a Univariate relative risk calculated from numbers provided in article.
b Hazard ratio.
Editorial / European Journal of Vascular and Endovascular Surgery 43 (2012) 254–256 255logistic model of the combined ADAM study cohorts10 was exam-
ined for associations with AAA larger than 4.0 cm compared with
AAA 3.0–3.9 cm in a previously unreported analysis, there is a nega-
tive association of larger AAA with diabetes (odds ratio 0.78, 95%
conﬁdence interval: 0.65–0.94), along with signiﬁcant positive
associations of larger AAA with age, smoking, and male gender.
These stronger associations probably result from less misclassiﬁca-
tion of AAA and the amplifying effect of disease severity20 when the
more extreme deﬁnition of AAA is used.
In addition to the studies of AAA occurrence listed in Table 1,
hospital discharge data from New York and Florida showed that
diabetics were less likely to have an AAA that was ruptured at the
time of repair,21 and several studies have reported that AAA
enlargement progresses more slowly in diabetics.22–26 One of these
focused on medication use rather than diagnoses26 and concluded
that “diabetes or its medications, or both, have a negative effect on
AAA growth”. If the negative association of AAA with diabetes is
mediated by drugs for diabetes, this would have to include older
drugs (insulin, sulfanylureas, and metformin) to account for the
earliest study results. While this remains a possibility, there are
several reasons to doubt a drug effect. First, the Health inMen study
reported a negative association between fasting glucose and aortic
diameter in 2859 non-diabetics.11 Second, investigators at Stanford
reported that hyperglycemia in mice was associated with slower
AAA enlargement, and this effect was diminished by insulin
therapy.27 These ﬁndings suggest that it is hyperglycemia, rather
than its treatment, that retards aneurysm progression.
The importance of the negative association between diabetes
and AAA lies not in an immediate clinical application but rather
in improving our understanding of pathophysiology. The divergent
effects of diabetes provide perhaps the strongest available
evidence that aneurismal and occlusive vascular disease are sepa-
rate entities2,28 and should be expected to have separate etiolo-
gies. The apparent protective effect of diabetes has led to
a variety of studies aimed at elucidating its mechanism, potentially
bringing us closer to understanding the etiology of AAA itself. For
example, the advanced glycation associated with diabetes has
been shown to induce cross-linking of collagen lattices in the
aortic media, and this cross-linking resists proteolysis and inhibits
secretion of the matrix metalloproteinases thought to mediate
AAA formation.24 Diabetes also suppresses plasmin, itself an acti-
vator of matrix metalloproteinases.29 These effects decrease aorticwall degradation directly and may also explain the thicker abdom-
inal aortic wall observed in diabetes. A thicker aortic wall reduces
wall stress by the Law of LaPlace,30 and wall stress is considered
fundamental to AAA development and progression.31
The rapidly growing body of work directed at explaining the
strange relationship between diabetes and AAA formation is
already deepening our understanding of AAA pathophysiology. If
this results in new treatments directed against this pathophysi-
ology, a better demonstration of the “bedside to bench to bedside”
paradigm32 would be hard to ﬁnd.References
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